Restarting Valsartan/HCTZ After a Prolonged Medication-Free Interval

Rationale for Dose Selection and Uptitration

• The American Heart Association recommends treating a patient who has been off medication for a prolonged period as if initiating therapy for the first time, as tolerance and physiologic adaptation to antihypertensive medications are lost after prolonged discontinuation 1, 2
• Starting with a conservative dose, such as valsartan 80 mg/HCTZ 12.5 mg, provides a balanced approach to efficacy and safety, particularly in elderly patients who may be more susceptible to orthostatic hypotension 3

Uptitration Strategy and Monitoring

• The American College of Cardiology recommends reassessing blood pressure within 2-4 weeks after initiating therapy to determine the need for uptitration 1, 2
• If blood pressure remains uncontrolled, consider increasing the dose to valsartan 160 mg/HCTZ 25 mg, and if necessary, to valsartan 320 mg/HCTZ 25 mg, before adding a third agent 1, 2, 3

Combination Therapy and Safety

• The European Society of Cardiology recommends using a combination of an angiotensin receptor blocker (ARB) and a thiazide diuretic, such as valsartan and HCTZ, as initial therapy for patients with hypertension, as it is more effective than monotherapy 1, 2, 3
• The combination of valsartan and HCTZ is effective in patients who previously failed monotherapy with either agent alone, and it attenuates HCTZ-induced hypokalemia, making it a safer option 3

Target Blood Pressure Goals and Monitoring

• The American Heart Association recommends targeting a blood pressure of <140/90 mmHg for most patients, and <130/80 mmHg for higher-risk patients, with individualized targets based on frailty and comorbidities 3, 4
• Regular monitoring of blood pressure, serum potassium, and creatinine is necessary to detect potential hypokalemia or changes in renal function, and to adjust the treatment plan accordingly 3